Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Viridian Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
26
−7 vs. Q1 2021
Shares held
6.00M
+460.2K (+8.3%) vs. Q1 2021
Total value
$109.8M
+$25.3M (+29.9%) vs. Q1 2021
New holders
4
10 more added
Sold out
11
4 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 26 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ2 2021: $109.8M
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q1 2021.

Institutions holding VRDN in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Ally Bridge Group (NY) LLC859,910$15.7M4.41%+179,142+26.3%Added
Perceptive Advisors LLC794,506$14.5M0.19%+794,506New
D. E. Shaw & Co., Inc.720,373$13.2M0.02%+531,861+282.1%Added
Wellington Management Group LLP578,560$10.6M0.00%00.0%Unchanged
Point72 Asset Management, L.P.395,534$7.23M0.04%00.0%Unchanged
Vanguard Group Inc354,066$6.48M0.00%+185,548+110.1%Added
BVF Inc350,081$6.40M0.24%−113,423−24.5%Reduced
Ghost Tree Capital, LLC350,000$6.40M2.00%+50,000+16.7%Added
Cormorant Asset Management, LP342,962$6.27M0.24%−116,182−25.3%Reduced
Ra Capital Management, L.P.312,328$5.71M0.09%00.0%Unchanged
Atlas Venture Advisors, Inc.209,505$3.83M0.40%00.0%Unchanged
Commodore Capital LP186,405$3.41M1.19%+624+0.3%Added
Balyasny Asset Management LLC119,478$2.19M0.01%−98−0.1%Reduced
Millennium Management LLC117,715$2.15M0.00%+74,539+172.6%Added
Bailard, Inc.90,500$1.66M0.06%−20,500−18.5%Reduced
BlackRock Inc.50,252$919.0K0.00%+19,365+62.7%Added
Geode Capital Management, LLC38,283$700.0K0.00%+15,389+67.2%Added
Fairmount Funds Management LLC35,092$642.0K0.26%00.0%Unchanged
Northern Trust Corp31,467$576.0K0.00%+31,467New
Silverarc Capital Management, LLC28,399$519.0K0.27%+813+2.9%Added
VR Adviser, LLC19,495$357.0K0.04%00.0%Unchanged
State Street Corp11,041$202.0K0.00%+11,041New
Morgan Stanley6,985$128.0K0.00%+6,985New
Wells Fargo & Company519$10.0K0.00%+29+5.9%Added
UBS Group AG13$00.00%00.0%Unchanged
GPS Wealth Strategies Group, LLC3$00.00%00.0%Unchanged
Logos Global Management LP0$00.00%−550,000−100.0%Sold out
Soleus Capital Management, L.P.0$00.00%−67,685−100.0%Sold out
Driehaus Capital Management LLC0$00.00%−33,333−100.0%Sold out
Maven Securities LTD0$00.00%−27,898−100.0%Sold out
Renaissance Technologies LLC0$00.00%−13,240−100.0%Sold out
Squarepoint Ops LLC0$00.00%−11,668−100.0%Sold out
Citadel Advisors LLC0$00.00%−485,995−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−950−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−118−100.0%Sold out
JPMorgan Chase & Co0$00.00%−10−100.0%Sold out
Bank of America Corp0$00.00%−16−100.0%Sold out